PATENT CLAIM ANALYSIS

Application Number: 15882924
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["514", "252160"]

Abstract:
The present invention relates to pharmaceutical compounds, compositions and methods, especially as they are related to compositions and methods for the treatment and/or prevention of a proliferation disorder, a cancer, a tumor, an inflammatory disease, an autoimmune disease, psoriasis, dry eye or an immunologically related disease, and in some embodiments diseases or disorders related to the dysregulation of kinase such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, FLT3(D835Y), ITK, TEC, TXK, BTK, or JAK, and the respective pathways.

Claim (Index 12):
The method of  claim 11 , wherein the proliferation disorder is selected from the group consisting of sarcoma, epidermoid cancer, fibrosarcoma, cervical cancer, gastric carcinoma, skin cancer, leukemia, lymphoma, lung cancer, non-small cell lung cancer, colon cancer, CNS cancer, melanoma, ovarian cancer, renal cancer, prostate cancer, breast cancer, liver cancer, head and neck cancers, and pancreatic cancer.

Metadata:
- Claim Count in Document: 66.0
- Percentile: 86.0
- Lexical Diversity: 1.68182
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14329890', '16068559', '13436910', '14712794', '13436963']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8052085571099962
- 35 USC 102 Novelty (BERT): 0.549894597615269
- Combined Prediction Score: 0.7796771611605234
- Mean Citation Score: 306.409536
- Max Citation Score: 426.96307
- Similarity Product: 313.1185754270745

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test